Theriva Biologics effects 1-for-25 reverse stock split to meet NYSE American price rules

Theriva Biologics, Inc.

Reverse split ratio of 1-for-25; shares reduced from 25,131,230 to approximately 1,005,249.
Effective 12:01 a.m. ET on August 26, 2024; trading began on post-split basis same day.
No fractional shares issued; holders otherwise entitled to fractional shares receive rounding up to next whole share.
Exercise price and share count under options, warrants, and equity plans adjusted proportionately.
Trading symbol unchanged ('TOVX'); new CUSIP number is 87164U508.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.